These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 23954313)

  • 1. Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome.
    Labus JS; Hubbard CS; Bueller J; Ebrat B; Tillisch K; Chen M; Stains J; Dukes GE; Kelleher DL; Naliboff BD; Fanselow M; Mayer EA
    Gastroenterology; 2013 Dec; 145(6):1253-61.e1-3. PubMed ID: 23954313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain.
    Hubbard CS; Labus JS; Bueller J; Stains J; Suyenobu B; Dukes GE; Kelleher DL; Tillisch K; Naliboff BD; Mayer EA
    J Neurosci; 2011 Aug; 31(35):12491-500. PubMed ID: 21880911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural circuitry of abdominal pain-related fear learning and reinstatement in irritable bowel syndrome.
    Icenhour A; Langhorst J; Benson S; Schlamann M; Hampel S; Engler H; Forsting M; Elsenbruch S
    Neurogastroenterol Motil; 2015 Jan; 27(1):114-27. PubMed ID: 25557224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Cerebellar Activity in Visceral Pain-Related Fear Conditioning in Irritable Bowel Syndrome.
    Claassen J; Labrenz F; Ernst TM; Icenhour A; Langhorst J; Forsting M; Timmann D; Elsenbruch S
    Cerebellum; 2017 Apr; 16(2):508-517. PubMed ID: 27797090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.
    Fukudo S
    J Gastroenterol; 2007 Jan; 42 Suppl 17():48-51. PubMed ID: 17238026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin Conductance Responses and Neural Activations During Fear Conditioning and Extinction Recall Across Anxiety Disorders.
    Marin MF; Zsido RG; Song H; Lasko NB; Killgore WDS; Rauch SL; Simon NM; Milad MR
    JAMA Psychiatry; 2017 Jun; 74(6):622-631. PubMed ID: 28403387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing factor receptor 1 (CRF-R1) antagonists: Promising agents to prevent visceral hypersensitivity in irritable bowel syndrome.
    Lv Y; Wen J; Fang Y; Zhang H; Zhang J
    Peptides; 2022 Jan; 147():170705. PubMed ID: 34822913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?
    Sweetser S; Camilleri M; Linker Nord SJ; Burton DD; Castenada L; Croop R; Tong G; Dockens R; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1299-306. PubMed ID: 19342506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin-releasing hormone receptor 1 (CRH-R1) polymorphisms are associated with irritable bowel syndrome and acoustic startle response.
    Orand A; Naliboff B; Gadd M; Shih W; Ju T; Presson AP; Mayer EA; Chang L
    Psychoneuroendocrinology; 2016 Nov; 73():133-141. PubMed ID: 27497153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Learning pain-related fear: neural mechanisms mediating rapid differential conditioning, extinction and reinstatement processes in human visceral pain.
    Gramsch C; Kattoor J; Icenhour A; Forsting M; Schedlowski M; Gizewski ER; Elsenbruch S
    Neurobiol Learn Mem; 2014 Dec; 116():36-45. PubMed ID: 25128878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome.
    Sagami Y; Shimada Y; Tayama J; Nomura T; Satake M; Endo Y; Shoji T; Karahashi K; Hongo M; Fukudo S
    Gut; 2004 Jul; 53(7):958-64. PubMed ID: 15194643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome.
    Larsson MB; Tillisch K; Craig AD; Engström M; Labus J; Naliboff B; Lundberg P; Ström M; Mayer EA; Walter SA
    Gastroenterology; 2012 Mar; 142(3):463-472.e3. PubMed ID: 22108191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fear conditioning in an abdominal pain model: neural responses during associative learning and extinction in healthy subjects.
    Kattoor J; Gizewski ER; Kotsis V; Benson S; Gramsch C; Theysohn N; Maderwald S; Forsting M; Schedlowski M; Elsenbruch S
    PLoS One; 2013; 8(2):e51149. PubMed ID: 23468832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
    Guilarte M; Vicario M; Martínez C; de Torres I; Lobo B; Pigrau M; González-Castro A; Rodiño-Janeiro BK; Salvo-Romero E; Fortea M; Pardo-Camacho C; Antolín M; Saperas E; Azpiroz F; Santos J; Alonso-Cotoner C
    Am J Gastroenterol; 2020 Dec; 115(12):2047-2059. PubMed ID: 32740086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome.
    Kano M; Muratsubaki T; Van Oudenhove L; Morishita J; Yoshizawa M; Kohno K; Yagihashi M; Tanaka Y; Mugikura S; Dupont P; Ly HG; Takase K; Kanazawa M; Fukudo S
    Sci Rep; 2017 Sep; 7(1):12425. PubMed ID: 28963545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral hypersensitivity in irritable bowel syndrome.
    Kanazawa M; Hongo M; Fukudo S
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRF1 receptors as a therapeutic target for irritable bowel syndrome.
    Martinez V; Taché Y
    Curr Pharm Des; 2006; 12(31):4071-88. PubMed ID: 17100612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome.
    Nozu T; Okumura T
    J Gastroenterol; 2015 Aug; 50(8):819-30. PubMed ID: 25962711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of corticotropin-releasing factor pathways in stress-related alterations of colonic motor function and viscerosensibility in female rodents.
    Taché Y; Million M; Nelson AG; Lamy C; Wang L
    Gend Med; 2005 Sep; 2(3):146-54. PubMed ID: 16290887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of corticotropin releasing factor receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome.
    Taché Y; Martinez V; Million M; Maillot C
    Eur J Surg Suppl; 2002; (587):16-22. PubMed ID: 16144197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.